We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Urges Evaluations of Healthcare Provider Communications
FDA Urges Evaluations of Healthcare Provider Communications
Drugmakers should routinely assess the effectiveness of “dear healthcare provider” letters that provide updated safety or usage information about a drug and make improvements where needed, the FDA said Wednesday.